Evidence map›Paper›PMID 30247974›Full record

ArticleJournal of alternative and complementary medicine (New York, N.Y.)

Integrative Oncology Scholars Program: A Model for Integrative Oncology Education.

Suzanna Maria Zick, Christina Czuhajewski, Judith M Fouladbakhsh, Heather Greenlee, Richard Edmund Harris, Norah Lynn Henry, Shruti Jolly, Tohfa Khabir, Jane Perlmutter, Tami Remington and 5 more

Abstract read
In one paragraph

Article in Journal of alternative and complementary medicine (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Suzanna Maria Zick1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Christina Czuhajewski1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Judith M Fouladbakhsh3 School of Nursing, Oakland University , Rochester, Michigan.
Heather Greenlee4 Department of Medical Oncology, Fred Hutchinson Cancer Research Center , Seattle, Washington.
Richard Edmund Harris1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Norah Lynn Henry5 Department of Internal Medicine, University of Utah , Salt Lake City, Utah.
Shruti Jolly1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Tohfa Khabir1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Jane Perlmutter6 Gemini Group , Ann Arbor, Michigan.
Tami Remington1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Detrick Snyder1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Lisa Spratke1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Brad Zebrack1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Erin Zettell1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
Rita Benn1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
University of Michigan–Ann Arbor · USFred Hutch Cancer Center · USGemini Computers (United States) · USOakland University · USUniversity of Utah · US

Funding

A Short Course for Creating Integrative Oncology LeadersR25CA203651 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUZANNA M. ZICK · 2017 to 2026
$1.5M
NCI NIH HHS R25 CA203651
6 · The paper itself

Abstract

objectivesOncology providers are often confronted by patients who use complementary or alternative therapies, but have limited knowledge or confidence on how to advise patients on appropriate use. Despite this, there are few opportunities for oncology providers to learn about complementary or alternative therapies, while at the same time there is a high demand for integrative oncology (IO) training. To address a gap in IO educational opportunities, and particularly for nonphysicians, we created the Integrative Oncology Scholars (IOS) Program. The program's goal is to train 100 IO leaders and facilitate partnerships between them and complementary practitioners.

designFour iterations of a year-long National Cancer Institute-funded educational program that combines in-person team-based learning and eLearning to teach the evidence, application, and philosophy supporting IO. SETTINGS: In-person sessions take place at the University of Michigan, and eLearning is implemented using a Canvas website (Instructure, Inc., Salt Lake City, UT). SUBJECTS: Nurses, social workers, physician assistants, psychologists, physicians, pharmacists, and physical/occupational therapists with active oncology practices. Educational intervention: Four cohorts of 25 oncology providers per year will learn the evidence base for complementary and alternative approaches to a wide number of oncology topics, including symptom control, dietary supplements commonly used by cancer patients, diet, and the utility of specific integrative approaches for common oncology side-effects such as fatigue. OUTCOME MEASURES: A mixed methods approach will be used to evaluate overall IOS Program progress and individual scholar's impact on IO research, education, and clinical endeavors.

resultsThe first cohort of 25 IOS has been recruited and their education will begin in Summer 2018. Scholars come from 13 states and represent 23 different healthcare systems.

conclusionsThe IOS Program has the potential to increase the number of trained IO providers, educators, and researchers in the United States.

Indexed as

Integrative OncologyComplementary TherapiesHealth PersonnelHumansIntegrative MedicineUnited Statesflipped classroomintegrative oncologyoncology educationteam-based learning

Identifiers

PMID30247974
PMCPMC6157348
OpenAlexW2893279480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.